Skip to content
sellWeak

Gilde Healthcare U.A. Cooperatieve IV sold $719k of LVTX

owner at LAVA Therapeutics NV. 475,027 shares at an average of $1.51, traded Oct 15, 2015, filed Oct 15, 2025.

Warning score
33
Value
$719k
475,027 shares
Holdings after
5,019,151
-9% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    10% owner
    +12
  • Trade size
    $719k at market
    +21
  • Share of holdings sold
    Sold 9.5% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001193125-25-240610, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Oct 13, 2025SOpen-market sale
Common Shares
-47,686$1.54$73k5,246,492Oct 15, 2025
Oct 14, 2025SOpen-market sale
Common Shares
-227,341$1.51$343k5,019,151Oct 15, 2025
Oct 15, 2015SOpen-market sale
Common Shares
-200,000$1.51$302k4,819,151Oct 15, 2025

Related signals

Other insiders at LAVA Therapeutics NV and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
57Moderate
LVTXsell
LAVA Therapeutics NV
Gilde Healthcare U.A. Cooperatieve IV
owner
$4.2M
2,871,370 shares
-97%
24Weak
LVTXsell
LAVA Therapeutics NV
Gilde Healthcare U.A. Cooperatieve IV
owner
$198k
126,992 shares
-2%
57Moderate
LVTXsell
LAVA Therapeutics NV
Versant Venture Capital VI, L.P.
owner
$4.1M
2,903,403 shares
-122%
47Moderate
LVTXsell
LAVA Therapeutics NV
Versant Venture Capital VI, L.P.
owner
$2.5M
1,684,434 shares
-49%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Gilde Healthcare U.A. Cooperatieve IV sold $719k of LVTX | InsiderTell